The funding will support clinical studies and laboratory validation of a semen-based assay that detects epigenetic changes linked to severe male infertility and potentially increased cancer risk.
Agilent Technologies will acquire digital pathology software provider Proscia in a deal valued at up to $270 million, expanding Agilent’s presence in digital diagnostics and enterprise pathology software.
CMS has released preliminary 2027 CLFS rates, with data showing weighted median payment cuts for over 1,100 test codes; annual reductions are capped at 15% from 2027 to 2029 under current policy.
The College of American Pathologists has updated 14 Cancer Protocols, mandating the Breast Phyllodes Tumor protocol for accreditation and revising breast biomarker and GIST molecular testing criteria, according to CAP.
A bipartisan Senate bill would require Medicare Administrative Contractors to review Local Coverage Determination requests within 60 days and mandate stakeholder input, aiming to streamline and increase transparency in the coverage process.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
CND Life Sciences has opened a dedicated Innovation Laboratory in Scottsdale, Ariz., to expand assay development and biomarker research for neurodegenerative diseases, operating separately from its CLIA-certified clinical lab.
Urinalysis comparison guide featuring testing capabilities, technology, throughput, connectivity, sample capacity, and key specifications from leading systems.